The traditional image of liver disease as an ailment of adulthood or chronic substance abuse is being dismantled as a silent epidemic takes hold of the pediatric population. In Mangaluru, the surge of fatty liver disease among children is not merely a localized medical trend, but a stark indicator of a broader metabolic crisis driven … Read more
The Metabolic Time Bomb: Why Metabolic Liver Disease is the Next Global Health Crisis By 2050, nearly 2 billion people worldwide are projected to be affected by metabolic liver disease, a staggering figure that signals a looming public health catastrophe. This is no longer a condition reserved for the elderly or those with chronic alcohol … Read more
Nula Therapeutics Targets Metabolic Disease via Groundbreaking Nuclear Envelope Restoration In a significant leap for cellular medicine, Nula Therapeutics has emerged to challenge the current paradigm of metabolic healthcare. The biotech startup is developing an entirely new class of medicines designed to combat metabolic dysfunction by targeting a previously overlooked cellular frontier: the nuclear envelope. … Read more
The “weekend warrior” approach to alcohol consumption—abstaining during the week only to indulge in heavy sessions on Friday and Saturday—may be far more dangerous than previously understood. New research suggests that for a significant portion of the population, the pattern of drinking is a more critical predictor of liver failure than the total volume of … Read more
The seemingly harmless habit of occasional binge drinking – defined as four or more drinks for women and five or more for men in a single sitting – carries a surprisingly high risk: a tripling of the chance of developing advanced liver fibrosis, particularly for those already grappling with metabolic dysfunction-associated steatotic liver disease (MASLD). … Read more
The narrative around cannabis is undergoing a significant shift, moving beyond recreational and even medicinal discussions towards a potential weapon in the fight against metabolic disease. New research published in the British Journal of Pharmacology reveals that compounds found in cannabis – specifically Cannabidiol (CBD) and Cannabigerol (CBG) – demonstrate a remarkable ability to improve … Read more
The Silent Pandemic: How Fatty Liver Disease is Reshaping Global Healthcare – and What’s Next Over 25% of the global population now lives with non-alcoholic fatty liver disease (NAFLD), a figure projected to climb to over 30% by 2030. This isn’t merely a health concern; it’s a looming economic burden and a stark warning about … Read more
Silent Threat: How AI-Powered Diagnostics Will Revolutionize Fatty Liver Disease Detection Nearly 25% of the global population is estimated to have non-alcoholic fatty liver disease (NAFLD), a figure projected to climb dramatically in the next decade. But what’s truly alarming is how often it goes undetected – until it’s potentially too late. Beyond the well-known … Read more